11 results for “DMD”
A consolidated AAV system for single-cut CRISPR correction of a common Duchenne muscular dystrophy mutation
Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species
A translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of Duchenne muscular dystrophy
Persistent expression of FLAG-tagged micro dystrophin in nonhuman primates following intramuscular and vascular delivery
The study will evaluate the safety and efficacy of gene transfer therapy in boys with DMD. It is a randomized, double-blind, placebo-controlled study. The participants who are randomized to the placebo arm will have an opportunity for treatment with gene transfer therapy at the beginning of the second year.
Engineered variant of Staphylococcus aureus Cas9 carrying three substitutions in the PAM-interacting domain - E782K, N968K, and R1015H - that relax the wild-type NNGRRT PAM to NNNRRT. Expands the number of targetable genomic sites two- to fourfold over wild-type SaCas9 while retaining its compact size for single-AAV delivery.